Laboratory Co. of America (LH) Stock Price, News & Analysis

Company Overview

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Key Stats

• Today's Range: $236.95 to $242.74
• 50-Day Range: $226.31 to $246.22
• 52-Week Range: $191.97 to $247.99
• Volume: 702,644 shs
• Average Volume: 409,791 shs
• Market Capitalization: $19.94 billion
• P/E Ratio: 46.12
• Dividend Yield: 1.21%
• Price Target: $260.54
• Consensus Rating: Moderate Buy

Laboratory Co. of America Stock Analysis - MarketRank™

Laboratory Co. of America scored higher than 96% of companies evaluated by MarketBeat, and ranked 45th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 2.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Laboratory Co. of America has received a consensus rating of Moderate Buy. The company's average rating score is 2.88, and is based on 12 buy ratings, 3 hold ratings, and no sell ratings.

Amount of Analyst Coverage

Laboratory Co. of America has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 9.92%

Earnings Growth

Earnings for Laboratory Co. of America are expected to grow by 9.92% in the coming year, from $14.51 to $15.95 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Laboratory Co. of America is 46.12, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 111.80.

Price to Earnings Ratio vs. Sector

The P/E ratio of Laboratory Co. of America is 46.12, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 89.34.

Price to Earnings Growth Ratio

Laboratory Co. of America has a PEG Ratio of 1.73. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Laboratory Co. of America has a P/B Ratio of 2.57. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.30% of the float of Laboratory Co. of America has been sold short.

Short Interest Ratio / Days to Cover

Laboratory Co. of America has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Laboratory Co. of America has recently decreased by 2.54%, indicating that investor sentiment is improving.

Dividend

• Score: 2.5 / 5
• Dividend Strength: Moderate

Dividend Yield

Laboratory Co. of America pays a meaningful dividend of 1.21%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Laboratory Co. of America does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Laboratory Co. of America is 55.71%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Laboratory Co. of America will have a dividend payout ratio of 18.06% next year. This indicates that Laboratory Co. of America will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 4.2 / 5
• Environmental Score: -0.66

Percentage of Shares Shorted

2.30% of the float of Laboratory Co. of America has been sold short.

Short Interest Ratio / Days to Cover

Laboratory Co. of America has a short interest ratio ("days to cover") of 3.3, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Laboratory Co. of America has recently decreased by 2.54%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.4 / 5
• News Sentiment: 1.38

News Sentiment

Laboratory Co. of America has a news sentiment score of 1.38. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.44 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 9 news articles for Laboratory Co. of America this week, compared to 10 articles on an average week.

Search Interest

Only 1 people have searched for LH on MarketBeat in the last 30 days. This is a decrease of -90% compared to the previous 30 days.

MarketBeat Follows

Only 2 people have added Laboratory Co. of America to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Laboratory Co. of America insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $6,145,209.00 in company stock.

Percentage Held by Insiders

Only 0.85% of the stock of Laboratory Co. of America is held by insiders.

Percentage Held by Institutions

95.94% of the stock of Laboratory Co. of America is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

LH Stock Analysis - Frequently Asked Questions

How have LH shares performed this year?

Laboratory Co. of America's stock was trading at $229.32 at the start of the year. Since then, LH shares have increased by 4.0% and is now trading at $238.4350.
View the best growth stocks for 2025 here.

How were Laboratory Co. of America's earnings last quarter?

Laboratory Co. of America Holdings (NYSE:LH) issued its quarterly earnings data on Thursday, October, 24th. The medical research company reported $3.50 EPS for the quarter, beating analysts' consensus estimates of $3.48 by $0.02. The business's quarterly revenue was up 7.4% on a year-over-year basis.
Read the conference call transcript.

Does Laboratory Co. of America have any subsidiaries?

Laboratory Co. of America subsidiaries include these companies: Clinical Outreach Laboratory Services, Personal Genome Diagnostics Inc., Toxikon Corporation, Myriad Autoimmune’s Vectra Testing Business, Ovia Health, Visiun, Envigo's nonclinical contract research services business, and others.

Who are Laboratory Co. of America's major shareholders?

Top institutional shareholders of Laboratory Co. of America include Nordea Investment Management AB (1.26%), Bartlett & CO. Wealth Management LLC (0.25%), AMI Asset Management Corp (0.24%) and Wedge Capital Management L L P NC (0.15%). Insiders that own company stock include Adam H Schechter, Glenn A Eisenberg, Lance Berberian, Brian J Caveney, Paul R Kirchgraber, Kerrii B Anderson, Dwight Gary Gilliland, Mark S Schroeder, Amy B Summy, Jonathan P Divincenzo, Der Vaart Sandra D Van, Peter J Wilkinson, Peter M Neupert and R Sanders Williams.
View institutional ownership trends.

How do I buy shares of Laboratory Co. of America?

Shares of LH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Laboratory Co. of America own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Laboratory Co. of America investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

• Last Earnings: 10/24/2024
• Ex-Dividend for 12/13 Dividend: 11/26/2024
• Dividend Payable: 12/13/2024
• Today: 1/20/2025
• Next Earnings (Estimated): 2/06/2025
• Dividend Payable: 3/12/2025
• Fiscal Year End: 12/31/2025
• Ex-Dividend for 3/12 Dividend: 1/01/2100

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical laboratories
• Sub-Industry: Health Care Services
• Current Symbol: NYSE:LH
• Previous Symbol: NYSE:LH?
• CUSIP: 50540R40
• CIK: 920148
• Web: www.labcorp.com
• Phone: (336) 229-1127
• Fax: 336-513-4510
• Employees: 67,000
• Year Founded: 1995

Price Target and Rating

• Average Stock Price Target: $260.54
• High Stock Price Target: $289.00
• Low Stock Price Target: $230.00
• Potential Upside/Downside: +9.3%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.88
• Research Coverage: 16 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $5.17
• Trailing P/E Ratio: 46.12
• Forward P/E Ratio: 16.43
• P/E Growth: 1.73
• Net Income: $418 million
• Net Margins: 3.43%
• Pretax Margin: 4.94%
• Return on Equity: 15.27%
• Return on Assets: 7.13%

Debt

• Debt-to-Equity Ratio: 0.66
• Current Ratio: 1.44
• Quick Ratio: 1.30

Sales & Book Value

• Annual Sales: $12.71 billion
• Price / Sales: 1.57
• Cash Flow: $20.90 per share
• Price / Cash Flow: 11.41
• Book Value: $92.76 per share
• Price / Book: 2.57

Miscellaneous

• Outstanding Shares: 83,639,000
• Free Float: 82,928,000
• Market Cap: $19.94 billion
• Optionable: Optionable
• Beta: 1.06